Cancer Stem Cell Tumorsphere Formation Protocol

Introduction

Solid tumors grow in a three-dimensional (3D) spatial conformation, resulting in a heterogeneous exposure to oxygen and nutrients as well as to other physical and chemical stresses. To mimic the 3D spatial conformation, 3D in vitro culture models have been used in cancer research. Cancer stem cells (CSCs) are defined as a small subset of cells within a tumor with the ability to self-renew and often drive tumor progression and recurrence after chemotherapy treatment. Traditionally, cancer stem cells have been isolated from cancer cell lines and tumor biopsies and grown in 3D tumorsphere suspension cultures.

Overview of the Tumorsphere Formation Protocol to generate 3D cancer stem cell spheroids

Figure 1.Overview of the Tumorsphere Formation Protocol

Tumorsphere Formation Protocol

  1. Detach the cells of a cancer stem cell-containing adherently growing cancer cell line using Trypsin-EDTA Solution (T3924). The cells should be 80–90% confluent and in good condition.
  2. Centrifuge the cell suspension for 5 minutes at 300 x g and aspirate the supernatant. Resuspend the cells in a small volume, e.g. 3–5 mL, of the 3dGRO™ Spheroid Medium (S3077).
  3. Count the cells (PHCC20060) and adjust the volume with 3dGRO™ Spheroid Medium to obtain a concentration of 1X106 cells/mL.
  4. Seed the cells in appropriate suspension culture vessels at 1X104 cells/mL, e.g. 40,000 cells in 4 ml of 3dGRO™ Spheroid Medium in each well of a Corning® Costar® Ultra-Low attachment multiwell plate (CLS3471).
  5. Incubate the culture for 4–10 days, depending on the cell type used. Add one-half of the culture volume of fresh 3dGRO™ Spheroid Medium every 3–4 days. Do not change all the media at once like traditional 2D cell culture.
  6. Passage the tumorsphere culture before they start to develop a dark center. The optimal passage should be done after 4-10 days depending on the cell type used.
  7. Collect the tumorspheres by transferring the cells and media into 15 mL conical tubes using a serological pipet.
  8. Allow the spheres to settle by gravity sedimentation for 10 minutes at room temperature. Aspirate the supernatant, but leave approximately 200 μL in the conical tube. Be careful not to aspirate the tumorspheres.
  9. Repeat the step 7-8 with an equal volume of PBS (D8662). Gently aspirate the PBS leaving approximately 200 μL in the conical tube.
  10. Add 1 mL of Trypsin-EDTA (T3924) solution to the tumorspheres and incubate for 2–4 minutes at room temperature. Keep the spheres resuspended in the trypsin solution by pipetting up and down once every 30 seconds. Avoid sedimentation of the spheres.
    Note: The optimal incubation time required to achieve complete dissociation must be determined empirically by the user for each cell type. While 2–3 minutes will be optimal in most cases, tumorspheres of some cell types, e.g. MCF-7, may need longer incubation, especially in higher passages. If a completely defined dissociation process is preferred, a recombinant trypsin (T3449) solution may be used as an alternative dissociation reagent according to the supplier`s instructions.
  11. Pipet the spheres up and down 10–20 times using a 1000 μL pipet tip to generate a single cell suspension. Aspirate the cell suspension as normal but tilt the pipet tip slightly at the bottom of the tube when expelling the cells. The shear forces generated facilitate the breakup of any residual cell aggregates. Perform a visual check to confirm that no large cell aggregates remain. Immediately after trituration, add twice the volume of Trypsin Neutralization Solution (T6414) or media.
    Note: Do not over-triturate as cell viability will be compromised. Non-dissociated cell aggregates may be removed by passing the cell suspension through a 40 μM cell strainer.
  12. Determine the cell number and viability. Centrifuge the cells for 5 minutes at 300 x g. Discard the supernatant and resuspend the cells in fresh 3dGRO™ Spheroid Medium at 1X106 cells/ml.
  13. Reseed the cells at 1X104 cells/mL in new Corning® Costar® Ultra-Low attachment multiwell plate (CLS3471). Typically, 6-well plates with 4X104 cells in 4 mL of medium per well are used.

Typical Results

Figure 2 MCF

Figure 1. Tumorsphere formation of MCF7 Breast Cancer Cells at Passage 1 (A) and Passage 5 (B) cultured in 3dGRO™ Spheroid Medium.

Turmosphere Formation of E006AA

Figure 2.Tumorsphere formation of E006AA Prostate Cancer Cells at Passage 1 (A) and Passage 5 (B) cultured in 3dGRO™ Spheroid Medium.

Tips and Tricks

Some cells, for example E3006AA cells, show growth inhibition or attachment to the 3D culture plates in first several passages however they will be adapted to the 3D culture and proliferate again around after 3rd passage.

Materials
Loading

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

MilliporeSigma

Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.